Intradialytic Administration of Daptomycin in End Stage Renal Disease Patients on Hemodialysis
AUTOR(ES)
Salama, Noha N.
FONTE
American Society of Nephrology
RESUMO
Background and objectives: Infusion of intravenous antibiotics after hemodialysis (HD) may delay initiation of treatment for the next HD shift. Intradialytic administration of drugs such as vancomycin during the final hour of HD obviates these delays. Daptomycin has potent activity against Gram-positive bacteria, but the manufacturer recommends that the dose be infused after HD ends. This study determined the pharmacokinetics of intradialytically dosed daptomycin in patients with ESRD.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2709518Documentos Relacionados
- Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
- Pharmacokinetics of Cefaclor in Patients with End Stage Renal Disease and During Hemodialysis
- A study of pulmonary function in end-stage renal disease patients on hemodialysis: a cross-sectional study
- Hemodialysis improves endothelial venous function in end-stage renal disease
- Hemodialysis improves endothelial venous function in end-stage renal disease
